After Last Patient Last Visit, the science is done, yet submissions take months and regulatory review months more. This white paper examines why, and how a study kept continuously validated against its own code can be submitted within days of LPLV.

Learn how the Verisian Harness makes agentic AI trustworthy in clinical trials, how experts stay in control at every quality gate, and what changes for planning, validation, submission documents, study pooling and regulatory review.

Enter your details for instant access to the white paper. The information you provide will be used in accordance with the terms of our Privacy Policy.